Special situations investor Promethean Investments has reached a first close for its latest fund on £19m.
Acquisition aims to boost Capza's growth capital offering ahead of the launch of its growth fund
Biotech company has so far raised $95m over two funding rounds
Listed private equity investor is currently valued at £315 per share, at the time of publication
Following the acquisition of optician chain Ounda, BCP is screening IT and business services deals